Results 231 to 240 of about 22,856,606 (379)

Reducing Time Complexity in RFID Systems [PDF]

, 2006
Gildas Avoine, Etienne Dysli, Philippe Oechslin   +2 more
openalex   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Modeling strategies for a flexible estimation of the crude cumulative incidence in the context of long follow-ups: model choice and predictive ability evaluation. [PDF]

BMC Med Res Methodol
Biganzoli G, Marano G, Boracchi P.
europepmc   +1 more source

On the time complexity of 2-tag systems and small universal Turing machines [PDF]

, 2006
Damien Woods, Turlough Neary
openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

Information thinking: the transformation of complexity and scientific thinking. [PDF]

Front Psychol
Wu T, Zhang H, Wu K.
europepmc   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

Simple matters in complex times [PDF]

American Journal of Hematology, 2017
openaire   +3 more sources

Differential Diagnosis Assessment in Ambulatory Care With a Digital Health History Device: Pseudorandomized Study. [PDF]

JMIR Form Res
Healey B, Schwitzguebel A, Spechbach H.
europepmc   +1 more source

Time Complexity Analysis of Support Vector Machines (SVM) in LibSVM

, 2015
Abdiansah Abdiansah, Retantyo Wardoyo
semanticscholar   +1 more source